The award seems quite excessive, and Breggin is a well known critic of psychiatric medications. In his own article he says that the defendant was in jail for vandalizing the property of a competing business and that paxil (which the defendant had been on for years) was the reason the defendant committed that crime (seriously, look at the link posted above!). It sounds like he's willing to testify that paxil is responsible for any bad behavior a person exhibits while taking it. That said, akathisia could have contributed to the suicide. We don't know anything other than medication dosing and that the patient appeared to be in bad shape when a psychologist saw him so who knows?
With that said, I think that this is more of a cautionary tale about doing lazy assessment and management rather than a prohibition on paxil use. It seems the ordering psychiatrist never evaluated the patient at all. The psychologist, who apparently evaluated the patient later, said the patient was "extremely anxious and like a “cornered rat,” spoke very little, made poor eye contact, and looked hunched over and withdrawn." Despite this the psychologist did not evaluate the time course of the patient's symptoms, did not evaluate for suicidal thoughts, and only documented "rule out depression."
I think if we demonstrate that we gathered the relevant data and exercised clinical judgment juries are likely to be kinder in their assessments, even if there is a bad outcome.